Fowlicidin-1 (8-26)[T5W, I7R, N11K]
General Information
DRACP ID DRACP03872
Peptide Name Fowlicidin-1 (8-26)[T5W, I7R, N11K]
Sequence LVIRWVRAGYKLYRAIKKK
Sequence Length 19
UniProt ID Q6QLQ5
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Active ACP
Activity Information
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer; Antibacterial
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Amidation
Other Modification None
Chiral L
Physicochemical Information
Formula C113H189N33O22
Absent amino acids CDEFHMNPQST
Common amino acids K
Mass 268320
Pl 11.75
Basic residues 7
Acidic residues 0
Hydrophobic residues 9
Net charge 7
Boman Index -3259
Hydrophobicity -23.16
Aliphatic Index 123.16
Half Life
Mammalian: 100 hour
Yeast: >20 hour
E.coli: >10 hour
Extinction Coefficient cystines 8480
Absorbance 280nm 471.11
Polar residues 3
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 31473417
Title The design of a cell-selective fowlicidin-1-derived peptide with both antimicrobial and anti-inflammatory activities
Doi Not available
Year 2019
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
External Code
DBAASP ID 13895